Schrödinger, Inc. is a low-risk healthcare company based in the United States that focuses on ESG solutions for drug discovery. With a Risk Rating Score of 19.5, Schrödinger, Inc. operates in Software and Drug discovery segments. The Software segment offers ESG software solutions to transform drug discovery across various industries, while the Drug discovery segment generates revenue through preclinical and clinical programs, both internally and through collaborations. Schrödinger, Inc. earns revenues from software sales and research funding and milestone payments from drug discovery partnerships.